Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Applovin
APP
|
+$810M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$748M |
| 3 |
Palantir
PLTR
|
+$504M |
| 4 |
Union Pacific
UNP
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$366M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.88B |
| 2 |
Meta Platforms (Facebook)
META
|
+$719M |
| 3 |
Broadcom
AVGO
|
+$683M |
| 4 |
Bank of America
BAC
|
+$675M |
| 5 |
Wells Fargo
WFC
|
+$631M |
Sector Composition
| 1 | Technology | 16.39% |
| 2 | Financials | 13.7% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Middlesex Water
MSEX
$971M
| $932K | ﹤0.01% |
17,210
-37,166
| -68% | -$2.01M |
|
2952
Amerant Bancorp
AMTB
$880M
| $932K | ﹤0.01% |
51,137
-10,291
| -17% | -$188K |
|
2953
Actinium Pharmaceuticals
ATNM
$50.8M
| $929K | ﹤0.01% |
+663,269
| New | +$929K |
|
2954
Ichor Holdings
ICHR
$579M
| $927K | ﹤0.01% |
47,219
+26,346
| +126% | +$517K |
|
2955
Harmony Biosciences
HRMY
$1.86B
| $926K | ﹤0.01% |
29,289
-49,203
| -63% | -$1.55M |
|
2956
Regenxbio
RGNX
$465M
| $919K | ﹤0.01% |
111,949
-220,880
| -66% | -$1.81M |
|
2957
Opko Health
OPK
$1.11B
| $918K | ﹤0.01% |
695,780
-5,691,131
| -89% | -$7.51M |
|
2958
OmniAb
OABI
$236M
| $917K | ﹤0.01% |
650,316
+518,645
| +394% | +$732K |
|
2959
FS Bancorp
FSBW
$315M
| $916K | ﹤0.01% |
23,251
+1,898
| +9% | +$74.7K |
|
2960
Gevo
GEVO
$404M
| $915K | ﹤0.01% |
693,251
-2,585,010
| -79% | -$3.41M |
|
2961
Stratasys
SSYS
$835M
| $914K | ﹤0.01% |
79,690
+20,604
| +35% | +$236K |
|
2962
TScan Therapeutics
TCRX
$99.9M
| $914K | ﹤0.01% |
630,138
+398,963
| +173% | +$578K |
|
|
NPB
2963
Northpointe Bancshares, Inc.
NPB
$624M
| $911K | ﹤0.01% |
66,482
-105,795
| -61% | -$1.45M |
|
2964
Burke & Herbert Financial Services Corp
BHRB
$925M
| $909K | ﹤0.01% |
15,225
-14,372
| -49% | -$858K |
|
2965
Monarch Casino & Resort
MCRI
$1.9B
| $904K | ﹤0.01% |
10,463
-9,050
| -46% | -$782K |
|
2966
National Research Corp
NRC
$369M
| $904K | ﹤0.01% |
53,810
+11,770
| +28% | +$198K |
|
2967
Neumora Therapeutics
NMRA
$262M
| $903K | ﹤0.01% |
1,231,392
+513,066
| +71% | +$376K |
|
2968
Navigator Holdings
NVGS
$1.11B
| $897K | ﹤0.01% |
63,375
-479,381
| -88% | -$6.78M |
|
2969
Triumph Financial, Inc.
TFIN
$1.4B
| $894K | ﹤0.01% |
16,231
-12,359
| -43% | -$681K |
|
2970
Invivyd
IVVD
$299M
| $893K | ﹤0.01% |
+1,249,093
| New | +$893K |
|
2971
Banco Santander
SAN
$149B
| $892K | ﹤0.01% |
107,468
+72,708
| +209% | +$603K |
|
2972
Meridian
MRBK
$171M
| $888K | ﹤0.01% |
68,854
-136,290
| -66% | -$1.76M |
|
2973
Cardlytics
CDLX
$59.6M
| $887K | ﹤0.01% |
539,431
-166,206
| -24% | -$273K |
|
2974
LoveSac
LOVE
$258M
| $886K | ﹤0.01% |
48,664
-253,627
| -84% | -$4.62M |
|
|
MITT
2975
AG Mortgage Investment Trust
MITT
$244M
| $885K | ﹤0.01% |
117,242
-98,221
| -46% | -$742K |
|